Medicure Inc (MCUJF) stock
Close on Oct 19, 2026
Medicure Inc grew revenue 31.7% to C$28.86M over fiscal 2025.
Key statistics
Valuation at the latest close; fundamentals over fiscal 2025, balances at Dec 31, 2025
Valuation
- Market cap
- –
- P/E ratio
- –
- Price to sales
- –
- Price to book
- –
- Dividend yield
- –
- Free cash flow yield
- –
Fundamentals
- Revenue
- C$28.86M
- EPS, diluted
- -0.68 CAD
Trading
- Previous close
- $2.98
- Open
- $3.04
- Day's range
- $3.03 – $3.10
- Volume
- 11,355
- Average volume (20 days)
- 16,010
Valuation needs the share price. It fills in once daily prices are connected and converted from CAD.
Market cap history
Month-end market cap since 2016, using shares outstanding reported at the time
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Oct 19, 2026. The S&P 500 is measured by the SPY fund.
| Period | MCUJF | S&P 500 | Difference | MCUJF per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | +63.2% | +0.6% | +62.5 pts | ||
| 3 months | +262.4% | +3.4% | +259.0 pts | ||
| Year to date | +287.6% | +13.3% | +274.4 pts | ||
| 1 year | +297.4% | +16.6% | +280.8 pts | ||
| 3 years | +146.0% | +86.4% | +59.7 pts | +35.0% | +23.1% |
| 5 years | +287.5% | +81.9% | +205.6 pts | +31.1% | +12.7% |
| 10 years | -30.6% | +318.9% | −349.5 pts | -3.6% | +15.4% |
Twelve years at a glance
Fiscal years 2014 to 2025, CAD
Revenue
Gross profit
Operating income
EPS, diluted
Press releases
Releases Medicure filed with the SEC as exhibits to Form 8-K or 6-K
- 6-K
- 6-K
- 6-K
- 6-K
- 6-K
- 6-K
About Medicure
Pharmaceutical Preparations
Medicure Inc. is a pharmaceutical company that develops, commercializes, and distributes healthcare products primarily focused on cardiovascular therapeutics and retail pharmacy operations. Its marketed product portfolio includes cardiovascular medications such as AGGRASTAT and ZYPITAMAG, alongside an expanding pharmacy business segment comprising Marley Drug, Gateway Pharmacy, and West Olympia Pharmacy. The company supplies generic and specialty pharmaceuticals directly to patients, offering mail-order delivery without requiring insurance. Medicure serves a customer base consisting of drug wholesalers, hospital health systems, prescribers, and direct-to-consumer retail patients.
Company profile, executives and historyMedicure stock: common questions
What is Medicure's stock price?
MCUJF closed at $3.10 on Oct 19, 2026, up 4.07% on the day.
What is MCUJF's P/E ratio?
Medicure lost money over fiscal 2025 (diluted EPS -0.68 CAD), so it has no meaningful P/E ratio.
How much revenue does Medicure make?
Medicure reported revenue of C$28.86M for fiscal 2025, up 31.7% from a year earlier.
Does Medicure pay a dividend?
No. Medicure has not paid a cash dividend over the last twelve months.
How has MCUJF stock performed over the past year?
Including dividends, MCUJF returned +297.4% over the past year, against +16.6% for the S&P 500.
Who are Medicure's competitors?
Companies most similar to Medicure by business, industry and size include SBFM, LXRX, JAGX, CPIX, VRCA.
See a number that looks wrong?